CPTKW 10-K & 10-Q changes, risk factors and insider trading
Crown PropTech Acquisitions · OTC · Wholesale-Hardware · CIK 1827899 · All filings on SEC.gov
At a glance
What changed in the latest 10-K
Risk Factors
Removed heading “The Company has not yet filed its Quarterly Report on Form 10-Q for the quarters ending March 31, 2025, June 30, 2025 and September 30, 2025 (the “2025 10-Qs”) and thus is not current in its SEC reporting obligations, which may result in any investment in our securities involving a greater degree of risk.”
Largest changes
“The Company has not yet filed its Quarterly Report on Form 10-Q for the quarters ending March 31, 2025, June 30, 2025 and September 30, 2025 (the “2025 10-Qs”) and thus is not current in its SEC reporting obligations, which may result in any investment in our securities involving a greater degree of risk.”see in full comparison
We may not be able to complete our initial business combination within the time period prescribed in our Articles, in which case we would cease all operations except for the purpose of winding up and we would redeem our Public Shares and liquidate, in which case our Public Shareholders may receive onlysee in full comparison$11.70$11.84 per shareshare(based on the Trust Account balance as ofOctoberMarch31,9,20252026), or less than such amount in certain circumstances, and our warrants will expire worthless.
If third parties bring claims against us, thesee in full comparisonthefunds held in the trust account could be reduced and the per-share redemption amount received by shareholders may be less than$11.70$11.84 per share (based on the Trust Account balance as ofOctoberMarch31,9,20252026).
We may only be able to complete one business combination with the proceeds of the Initial Public Offering and the sale of the Private Placement Warrants, which will cause us to be solely dependent on a single business which may have a limited number of products or services. This lack of diversification may negatively impact our operations and profitability. Of the net proceeds from the Initial Public Offering and the Private Placement, as ofsee in full comparisonOctoberMarch31,9,2025,2026, up to$5,751,935$5,731,447 will be available to complete our initial business combination.
“Although the Company has dedicated significant resources to the completion of finalizing its consolidated financial statements and related disclosures for inclusion in the 2025 Form 10-Qs, the Company was unable to file the 2025 Form 10-Qs on a timely basis. Additional time is needed by the Company to complete its review of the financial statements included in the 2025 Form 10-Qs in order to ensure a complete, accurate Form 10-Q for the quarters ended March 31, 2025, June 30, 2025 and September 30, 2025. …”see in full comparison
Finally, any of the events described above, including the evolving and escalating conflict in Iran and the Middle East, and the ongoing impact of the recent conflict betweensee in full comparisonbetweenthe Israel and Hamas and the Russia-Ukraine war, may also have the effect of heightening many of the other risks described in this “Risk Factors” section, such as those related to the market for our securities and cross-border transactions.
Full comparison: every changed paragraph (33)
● If the net proceeds of the Initial Public Offering and the sale of the Private Placement Warrants not being held in the trust account are insufficient, it could limit the amount available to fund our search for a target business or businesses and complete our initial business combination, and we will depend on loans from our sponsors or management team to fund our search and to complete our initial business combination.
Our Initial Shareholders
own 93.3%93.4% of our issued and outstanding ordinary shares since the completion of Initial Public Offering. Our Initial Shareholders and
management team also may from time to time purchase Class A ordinary shares prior to our initial business combination. Our fifthsixth
amended and restated memorandum and articles of association provide that, if we seek shareholder approval of an initial business combination,
such initial business combination will be approved if we receive an ordinary resolution under Cayman Islands law, which requires the affirmative
vote of a majority of the shareholders who attend and vote at a general meeting of the company, including the Founder Shares. As a result,
our Initial Shareholders’ Founder Shares, would fulfill the majority vote needed to have our initial business combination approved.
We may not be able to complete our initial
business combination within the time period prescribed in our Articles, in which case we would cease all operations except for the purpose
of winding up and we would redeem our Public Shares and liquidate, in which case our Public Shareholders may receive only $11.70$11.84 per
share share
(based on the Trust Account balance as of OctoberMarch 31,9, 20252026), or less than such amount in certain circumstances, and our warrants will
expire worthless.
We may not be able to find
a suitable target business and complete our initial business combination by March 11, 2026.2027. Our ability to complete our initial business
combination may be negatively impacted by general market conditions, volatility in the capital and debt markets and the other risks described
herein, including as a result of terrorist attacks, natural disasters or a significant outbreak of infectious diseases. Additionally,
terrorist attacks, natural disasters or a significant outbreak of infectious diseases may negatively impact businesses we may seek to
acquire. If we have not completed our initial business combination within such time period, we will: (i) cease all operations except
for the purpose of winding up; (ii) as promptly as reasonably possible but not more than ten business days thereafter, redeem
the Public Shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the trust account, including
interest earned on the funds held in the trust account (less taxes payable and up to $100,000 of interest income to pay dissolution expenses),
divided by the number of then outstanding Public Shares, which redemption will completely extinguish Public Shareholders’ rights
as shareholders (including the right to receive further liquidation distributions, if any) and (iii) as promptly as reasonably possible
following such redemption, subject to the approval of our remaining shareholders and our board of directors, liquidate and dissolve, subject
in the case of clauses (ii) and (iii), to our obligations under Cayman Islands law to provide for claims of creditors and in all
cases subject to the other requirements of applicable law. In such case, our Public Shareholders may receive only $11.70$11.84 per share (based
on the Trust Account balance as of OctoberMarch 31,9, 20252026), or less than $10.00 per share, on the redemption of their shares, and our warrants
will expire worthless. See “—If third parties bring claims against us, the funds held in the trust account could be reduced
and the per-share redemption amount received by shareholders may be less than $11.70$11.84 per share (based on the Trust Account balance as
of OctoberMarch 31,9, 20252026)” and other risk factors herein.
Our Public Shareholders will
be entitled to receive funds from the trust account only upon the earliest to occur of: (i) our completion of an initial business
combination, and then only in connection with those Class A ordinary shares that such shareholder properly elected to redeem, subject
to the limitations and on the conditions described herein, (ii) the redemption of any Public Shares properly submitted in connection
with a shareholder vote to amend our fifthsixth amended and restated memorandum and articles of association (A) to modify the substance
or timing of our obligation to allow redemption in connection with our initial business combination or to redeem 100% of our Public Shares
if we do not complete our initial business combination by March 11, 20262027 or (B) with respect to any other material provisions relating
to shareholders’ rights or pre-initial business combination activity, and (iii) the redemption of our Public Shares if we have
not completed an initial business combination by March 11, 2026,2027, subject to applicable law and as further described herein. In no other
circumstances will a Public Shareholder have any right or interest of any kind in the trust account. Holders of warrants will not have
any right to the funds held in the trust account. Accordingly, to liquidate your investment, you may be forced to sell your Public Shares
or warrants, potentially at a loss.
If we seek shareholder approval
of our initial business combination and we do not conduct redemptions in connection with our initial business combination pursuant to
the tender offer rules, our fifthsixth amended and restated memorandum and articles of association provide that a Public Shareholder, together
with any affiliate of such shareholder or any other person with whom such shareholder is acting in concert or as a “group”
(as defined under Section 13 of the Exchange Act), will be restricted from seeking redemption rights with respect to more than an
aggregate of 15% of the shares sold in the Initial Public Offering without our prior consent, which we refer to as the “Excess Shares.”
However, we would not be restricting our shareholders’ ability to vote all of their shares (including Excess Shares) for or against
our initial business combination. Your inability to redeem the Excess Shares will reduce your influence over our ability to complete our
initial business combination and you could suffer a material loss on your investment in us if you sell Excess Shares in open market transactions.
Additionally, you will not receive redemption distributions with respect to the Excess Shares if we complete our initial business combination.
And as a result, you will continue to hold that number of shares exceeding 15% and, in order to dispose of such shares, would be required
to sell your shares in open market transactions, potentially at a loss.
We believe that the funds
available to us outside of the trust account will be sufficient to allow us to operate for at least until March 11, 20262027; however, we
cannot assure you that our estimate is accurate. If we are required to seek additional capital, we would need to borrow funds from our
sponsors, management team or other third parties to operate or may be forced to liquidate. Neither our sponsors, members of our management
team nor any of their affiliates is under any obligation to advance funds to us in such circumstances. Any such advances would be repaid
only from funds held outside the trust account or from funds released to us upon completion of our initial business combination. Prior
to the completion of our initial business combination, we do not expect to seek loans from parties other than our sponsors or an affiliate
of our sponsors as we do not believe third parties will be willing to loan such funds and provide a waiver against any and all rights
to seek access to funds in our trust account. If we are unable to complete our initial business combination because we do not have sufficient
funds available to us, we will be forced to cease operations and liquidate the trust account. Consequently, our Public Shareholders may
only receive an estimated $11.70$11.84 per share (based on the Trust Account balance as of OctoberMarch 31,9, 20252026), or possibly less, on our redemption
of our Public Shares, and our warrants will expire worthless.
If third parties bring claims against us,
the the
funds held in the trust account could be reduced and the per-share redemption amount received by shareholders may be less than $11.70$11.84
per share (based on the Trust Account balance as of OctoberMarch 31,9, 20252026).
Examples of possible instances
where we may engage a third party that refuses to execute a waiver include the engagement of a third-party consultant whose particular
expertise or skills are believed by management to be significantly superior to those of other consultants that would agree to execute
a waiver or in cases where management is unable to find a service provider willing to execute a waiver. In addition, there is no guarantee
that such entities will agree to waive any claims they may have in the future as a result of, or arising out of, any negotiations, contracts
or agreements with us and will not seek recourse against the trust account for any reason. Upon redemption of our Public Shares, if we
have not completed our initial business combination within the prescribed timeframe, or upon the exercise of a redemption right in connection
with our initial business combination, we will be required to provide for payment of claims of creditors that were not waived that may
be brought against us within the 10 years following redemption. Accordingly, the per-share redemption amount received by Public Shareholders
could be less than the $11.70$11.84] per Public Share initially held in the trust account (based on the Trust Account balance as of OctoberMarch 31,9,
20252026), due to claims of such creditors. Crown PropTech Sponsor has agreed that it will be liable to us if and to the extent any claims
by a third party (other than CBIZ CPAs P.C., our independent registered public accounting firm) for services rendered or products sold
to us, or a prospective target business with which we have entered into a written letter of intent, confidentiality or other similar agreement
or business combination agreement, reduce the amount of funds in the trust account to below the lesser of (i) $10.00 per Public Share
and (ii) the actual amount per Public Share held in the trust account as of the date of the liquidation of the trust account, if
less than $10.00 per share due to reductions in the value of the trust assets, less taxes payable, provided that such liability will
not apply to any claims by a third party or prospective target business who executed a waiver of any and all rights to the monies held
in the trust account (whether or not such waiver is enforceable) nor will it apply to any claims under our indemnity of the underwriters
of the Initial Public Offering against certain liabilities, including liabilities under the Securities Act. However, we have not asked
Crown PropTech Sponsor to reserve for such indemnification obligations, nor have we independently verified whether Crown PropTech Sponsor
has sufficient funds to satisfy its indemnity obligations and we believe that Crown PropTech Sponsor’s only assets are securities
of our company. Therefore, we cannot assure you that Crown PropTech Sponsor would be able to satisfy those obligations. As a result, if
any such claims were successfully made against the trust account, the funds available for our initial business combination and redemptions
could be reduced to less than $10.00 per Public Share. In such event, we may not be able to complete our initial business combination,
and you would receive such lesser amount per share in connection with any redemption of your Public Shares. None of our officers or directors
will indemnify us for claims by third parties including, without limitation, claims by vendors and prospective target businesses.
The proceeds held in the
trust account will be invested only in U.S. government treasury obligations with a maturity of 185 days or less or in money market
funds meeting certain conditions under Rule 2a-7 under the Investment Company Act, which invest only in direct U.S. government treasury
obligations. While short-term U.S. government treasury obligations currently yield a positive rate of interest, they have briefly yielded
negative interest rates in recent years. Central banks in Europe and Japan pursued interest rates below zero in recent years,
and the Open Market Committee of the Federal Reserve has not ruled out the possibility that it may in the future adopt similar policies
in the United States. In the event that we do not to complete our initial business combination or make certain amendments to our fifthsixth
amended and restated memorandum and articles of association, our Public Shareholders are entitled to receive their pro-rata share of the
proceeds held in the trust account, plus any interest income earned thereon (less taxes payable and up to $100,000 of interest income
to pay dissolution expenses). Negative interest rates could reduce the value of the assets held in trust such that the per-share redemption
amount received by Public Shareholders may be less than $10.00 per share.
We do not believe that our
anticipated principal activities will subject us to the Investment Company Act. To this end, the proceeds held in the trust account may
only be invested in United States “government securities” within the meaning of Section 2(a)(16) of the Investment Company
Act having a maturity of 185 days or less or in money market funds meeting certain conditions under Rule 2a-7 promulgated under
the Investment Company Act which invest only in direct U.S. government treasury obligations. Pursuant to the trust agreement, the trustee
is not permitted to invest in other securities or assets. By restricting the investment of the proceeds to these instruments, and by having
a business plan targeted at acquiring and growing businesses for the long term (rather than on buying and selling businesses in the manner
of a merchant bank or private equity fund), we intend to avoid being deemed an “investment company” within the meaning of
the Investment Company Act. An investment in us is not intended for persons who are seeking a return on investments in government securities
or investment securities. The trust account is intended as a holding place for funds pending the earliest to occur of either: (i) the
completion of our initial business combination; (ii) the redemption of any Public Shares properly submitted in connection with a
shareholder vote to amend our fifthsixth amended and restated memorandum and articles of association (A) to modify the substance or timing
of our obligation to allow redemption in connection with our initial business combination or to redeem 100% of our Public Shares if we
do not complete our initial business combination by March 11, 20262027 or (B) with respect to any other material provisions relating
to shareholders’ rights or pre-initial business combination activity; or (iii) absent an initial business combination by March
11, 20262027 our return of the funds held in the trust account to our Public Shareholders as part of our redemption of the Public Shares.
If we do not invest the proceeds as discussed above, we may be deemed to be subject to the Investment Company Act. If we were deemed to
be subject to the Investment Company Act, compliance with these additional regulatory burdens would require additional expenses for which
we have not allotted funds and may hinder our ability to complete a business combination. If we are unable to complete our initial business
combination, our Public Shareholders may only receive their pro rata portion of the funds in the trust account that are available for
distribution to Public Shareholders, and our warrants will expire worthless.
If we are unable to consummate
our initial business combination by March 11, 2026,2027, the funds then on deposit in the trust account, including interest earned on the funds
held in the trust account (less taxes payable and up to $100,000 of interest income to pay dissolution expenses), will be used to fund
the redemption of our Public Shares, as further described herein. Any redemption of Public Shareholders from the trust account will be
effected automatically by function of our fifthsixth amended and restated memorandum and articles of association prior to any voluntary winding
up. If we are required to wind-up, liquidate the trust account and distribute such amount therein, pro rata, to our Public Shareholders,
as part of any liquidation process, such winding up, liquidation and distribution must comply with the applicable provisions of the Companies
Act of the Cayman Islands, as amended (the “Companies Act”). In that case, investors may be forced to wait beyond the prescribed
timeframe before the redemption proceeds of our trust account become available to them, and they receive the return of their pro rata
portion of the funds from our trust account. We have no obligation to return funds to investors prior to the date of our redemption or
liquidation unless we consummate our initial business combination prior thereto and only then in cases where investors have sought to
redeem their Class A ordinary shares. Only upon our redemption or any liquidation will Public Shareholders be entitled to distributions
if we are unable to complete our initial business combination.
Our fifthsixth amended and restated
memorandum and articles of association authorize the issuance of up to 200,000,000 Class A ordinary shares, par value $0.0001 per
share, 20,000,000 Class B ordinary shares, par value $0.0001 per share, and 1,000,000 preferred shares, par value $0.0001 per share.
As of OctoberMarch 31,9, 2025,2026, there were 199,508,194199,516,178 and 13,100,000 authorized but unissued Class A ordinary shares and Class B ordinary
shares, respectively, available for issuance which amount does not take into account shares reserved for issuance upon exercise of outstanding
warrants, or shares issuable upon conversion of the Class B ordinary shares. The Class B ordinary shares are automatically convertible
into Class A ordinary shares concurrently with or immediately following the consummation of our initial business combination, initially
at a one-for-one ratio but subject to adjustment as set forth herein and in our fifthsixth amended and restated memorandum and articles of
association, including in certain circumstances in which we issue Class A ordinary shares or equity-linked securities related to
our initial business combination. As of OctoberMarch 31,9, 2025,2026, there were no preferred shares issued and outstanding.
We may issue a substantial
number of additional Class A ordinary shares or preferred shares to complete our initial business combination or under an employee
incentive plan after completion of our initial business combination. For example, we granted our Anchor Investor the option, but not the
obligation, to purchase up to 30% of our Class A ordinary shares, for a purchase price of $10.00 per Class A ordinary share,
in any financing transaction we may conduct in connection with our initial business combination. We may also issue Class A ordinary
shares upon conversion of the Class B ordinary shares at a ratio greater than one-to-one at the time of our initial business combination
as a result of the anti-dilution provisions as set forth therein. However, our fifthsixth amended and restated memorandum and articles of association
provide, among other things, that prior to our initial business combination, we may not issue additional shares that would entitle the
holders thereof to (i) receive funds from the trust account or (ii) vote on any initial business combination. These provisions
of our fifthsixth amended and restated memorandum and articles of association, like all provisions of our fifthsixth amended and restated memorandum
and articles of association, may be amended with a shareholder vote. The issuance of additional ordinary or preferred shares:
Until we consummate our initial
business combination, we intend to engage in the business of identifying and combining with one or more businesses. Each of our officers
and directors presently has, and any of them in the future may have, additional fiduciary or contractual obligations to other entities
pursuant to which such officer or director is or will be required to present a business combination opportunity to such entity. Accordingly,
they may have conflicts of interest in determining to which entity a particular business opportunity should be presented. These conflicts
may not be resolved in our favor and a potential target business may be presented to another entity prior to its presentation to us, subject
to their fiduciary duties under Cayman Islands law. Our fifthsixth amended and restated memorandum and articles of association provide that,
to the fullest extent permitted by applicable law: (i) no individual serving as a director or an officer shall have any duty, except
and to the extent expressly assumed by contract, to refrain from engaging directly or indirectly in the same or similar business activities
or lines of business as us; and (ii) we renounce any interest or expectancy in, or in being offered an opportunity to participate
in, any potential transaction or matter which may be a corporate opportunity for any director or officer, on the one hand, and us, on
the other.
We may only be able to complete one business
combination with the proceeds of the Initial Public Offering and the sale of the Private Placement Warrants, which will cause us to be
solely dependent on a single business which may have a limited number of products or services. This lack of diversification may negatively
impact our operations and profitability. Of the net proceeds from the Initial Public Offering and the Private Placement, as of OctoberMarch
31,9, 2025,2026, up to $5,751,935$5,731,447 will be available to complete our initial business combination.
The funds in the trust account
have, since our Initial Public Offering, been invested in U.S. government securities, within the meaning set forth in Section 2(a)(16)
of the Investment Company Act, with a maturity of 185 days or less or in any open-ended investment company that holds itself out as a
money market fund meeting the conditions of Rule 2a-7 of the Investment Company Act, as determined by the Company. As of OctoberMarch 31,9, 2025,2026,
amounts held in trust account included approximately $833,875$893,227 of accrued interest. To mitigate the risk of us being deemed to have been
operating as an unregistered investment company under the Investment Company Act, we may, in our discretion, on or prior to, March 11,
2026,2027, instruct Continental Stock Transfer & Trust Company, the trustee with respect to the trust account, to liquidate the U.S.
government securities or money market funds held in the trust account and thereafter to hold all funds in the trust account in cash (i.e.,
in one or more bank accounts) until the earlier of the consummation of an initial business combination or our liquidation. Following such
a liquidation of the assets in our trust account, we would likely receive minimal interest, if any, on the funds held in the trust account,
which would reduce the dollar amount our public shareholders would otherwise receive upon any redemption or liquidation of the Company
if the assets in the trust account had remained in U.S. government securities or money market funds. This means that the amount available
for redemption may not increase in the future.
We are aware of litigation
claiming that certain SPACs should be considered investment companies. Although we believe that these claims are without merit, we cannot
guarantee that we will not be deemed to be an investment company and thus subject to the Investment Company Act. Notwithstanding our investment
activities or the mitigation measures included herein, we could still be deemed to be or have been an investment company at any time since
our inception. If we are deemed to be subject to the Investment Company Act, compliance with these additional regulatory burdens would
require additional expenses for which we have not allotted funds and may hinder our ability to complete an initial business combination
or may result in our winding down our operations and our liquidation. If we are unable to complete our initial business combination, our
public shareholders may receive only approximately $11.70$11.84 (as of OctoberMarch 31,9, 20252026) on the liquidation of our trust account, and our public
shareholders would also lose the possibility of an investment opportunity in a target company.
Our fifthsixth amended and restated
memorandum and articles of association provide that in no event will we redeem our Public Shares in an amount that would cause our net
tangible assets to be less than $5,000,001. In addition, our proposed initial business combination may impose a minimum cash requirement
for (i) cash consideration to be paid to the target or its owners, (ii) cash for working capital or other general corporate
purposes or (iii) the retention of cash to satisfy other conditions. As a result, we may be able to complete our initial business
combination even though a substantial majority of our Public Shareholders do not agree with the transaction and have redeemed their shares
or, if we seek shareholder approval of our initial business combination and do not conduct redemptions in connection with our initial
business combination pursuant to the tender offer rules, have entered into privately negotiated agreements to sell their shares to our
sponsors, officers, directors, advisors or any of their affiliates. In the event the aggregate cash consideration we would be required
to pay for all Class A ordinary shares that are validly submitted for redemption plus any amount required to satisfy cash conditions
pursuant to the terms of the proposed business combination exceed the aggregate amount of cash available to us, we will not complete the
business combination or redeem any shares, all Class A ordinary shares submitted for redemption will be returned to the holders thereof,
and we instead may search for an alternate business combination.
In order to effectuate an initial business
combination, special purpose acquisition companies have, in the recent past, amended various provisions of their charters and other governing
instruments, including their warrant agreements. We have amended and restated our fourthfifth amendment and restatement memorandum and articles
of association and cannot assure you that we will not seek to amend our fifthsixth amended and restated memorandum and articles of association
or governing instruments in a manner that will make it easier for us to complete our initial business combination that our shareholders
may not support.
In order to effectuate a
business combination, special purpose acquisition companies have, in the recent past, amended various provisions of their charters and
governing instruments, including their warrant agreements. For example, special purpose acquisition companies have amended the definition
of business combination, increased redemption thresholds and extended the time to consummate an initial business combination and, with
respect to their warrants, amended their warrant agreements to require the warrants to be exchanged for cash and/or other securities.
We have amended and restated our fourthfifth amendment and restatement memorandum and articles of association. Further amending our fifthsixth amended
and restated memorandum and articles of association requires a special resolution under Cayman Islands law, which requires the affirmative
vote of a majority of at least two-thirds of the shareholders who attend and vote at a general meeting of the company, and amending our
warrant agreement will typically require a vote of holders of at least 65% of the public warrants and any amendment that solely affects
the terms of the Private Placement Warrants or any provision of the warrant agreement solely with respect to the Private Placement Warrants
will also require at least 65% of the then outstanding Private Placement Warrants. In addition, our fifthsixth amended and restated memorandum
and articles of association require us to provide our Public Shareholders with the opportunity to redeem their Public Shares for cash
if we propose an amendment to our fifthsixth amended and restated memorandum and articles of association (A) to modify the substance or
timing of our obligation to allow redemption in connection with our initial business combination or to redeem 100% of our Public Shares
if we do not complete an initial business combination by March 11, 20262027 or (B) with respect to any other material provisions relating
to shareholders’ rights or pre-initial business combination activity. To the extent any of such amendments would be deemed to fundamentally
change the nature of the securities offered through this registration statement, we would register, or seek an exemption from registration
for, the affected securities. We cannot assure you that we will not seek to amend our charter or governing instruments or extend the time
to consummate an initial business combination in order to effectuate our initial business combination.
The provisions of our fifthsixth amended and restated
memorandum and articles of association that relate to our pre-business combination activity (and corresponding provisions of the agreement
governing the release of funds from our trust account) may be amended with the approval of holders of not less than two-thirds of our
ordinary shares who attend and vote at a general meeting of the company (or two-thirds of our ordinary shares who attend and vote at a
general meeting of the company with respect to amendments to the trust agreement governing the release of funds from our trust account),
which is a lower amendment threshold than that of some other special purpose acquisition companies. It may be easier for us, therefore,
to further amend our fifthsixth amended and restated memorandum and articles of association and the trust agreement to facilitate the completion
of an initial business combination that some of our shareholders may not support.
Our fifthsixth amended and restated
memorandum and articles of association provide that any of its provisions related to pre-business combination activity (including the
requirement to deposit proceeds of the Initial Public Offering and the Private Placement into the trust account and not release such
amounts amounts
except in specified circumstances, and to provide redemption rights to Public Shareholders as described herein) may be amended
if approved
by special resolution, under Cayman Islands law which requires the affirmative vote of a majority of at least two-thirds
of the shareholders
who attend and vote at a general meeting of the company, and corresponding provisions of the trust agreement governing
the release of
funds from our trust account may be amended if approved by holders of two-thirds of our ordinary shares who attend and
vote at a general
meeting of the company. Our Initial Shareholders, who collectively beneficially own 93.3%93.4% of our ordinary shares, will
participate in
any vote to amend our fifthsixth amended and restated memorandum and articles of association and/or trust agreement and will
have the discretion
to vote in any manner they choose. As a result, we may be able to further amend the provisions of our fifthsixth amended
and restated memorandum
and articles of association which govern our pre-business combination behavior more easily than some other special
purpose acquisition
companies, and this may increase our ability to complete a business combination with which you do not agree. Our
shareholders may pursue
remedies against us for any breach of our fifthsixth amended and restated memorandum and articles of association.
Our Initial Shareholders,
officers and directors have agreed, pursuant to a letter agreement with us, that they will not propose any amendment to our fifthsixth amended
and restated memorandum and articles of association (A) to modify the substance or timing of our obligation to allow redemption in
connection with our initial business combination or to redeem 100% of our Public Shares if we do not complete our initial business combination
by March 11, 20262027 or (B) with respect to any other material provisions relating to shareholders’ rights or pre-initial business
combination activity, unless we provide our Public Shareholders with the opportunity to redeem their Class A ordinary shares upon
approval of any such amendment at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the trust account,
including interest earned on the funds held in the trust account and not previously released to us to pay our taxes, divided by the number
of then outstanding Public Shares. Our shareholders are not parties to, or third-party beneficiaries of, these agreements and, as a result,
will not have the ability to pursue remedies against our sponsors, officers or directors for any breach of these agreements. As a result,
in the event of a breach, our shareholders would need to pursue a shareholder derivative action, subject to applicable law.
Our Initial Shareholders
currently own 93.3%93.4% of our issued and outstanding ordinary shares. Accordingly, they may exert a substantial influence on actions requiring
a shareholder vote, potentially in a manner that you do not support, including amendments to our fifthsixth amended and restated memorandum
and articles of association. Neither our Initial Shareholders nor, to our knowledge, any of our officers or directors, have any current
intention to purchase additional securities. Factors that would be considered in making such additional purchases would include consideration
of the current trading price of our Class A ordinary shares. In addition, our board of directors, whose members are appointed by
Crown PropTech Sponsor, is and will be divided into three classes, each of which will generally serve for a term of three years with
only one class of directors being appointed in each year. We may not hold an annual general meeting to appoint new directors prior
to the completion of our initial business combination, in which case all of the current directors will continue in office until at least
the completion of the business combination. If there is an annual general meeting, as a consequence of our staggered board of directors,
only a minority of the board of directors will be considered for appointment and our Initial Shareholders, because of their ownership
position, will have considerable influence regarding the outcome. Accordingly, our Initial Shareholders will continue to exert control
at least until the completion of our initial business combination.
Our corporate affairs are
governed by our fifthsixth amended and restated memorandum and articles of association, the Companies Act (as the same may be supplemented
or amended from time to time) and the common law of the Cayman Islands. We are also subject to the federal securities laws of the United
States. The rights of shareholders to take action against the directors, actions by minority shareholders and the fiduciary responsibilities
of our directors to us under Cayman Islands law are to a large extent governed by the common law of the Cayman Islands. The common law
of the Cayman Islands is derived in part from comparatively limited judicial precedent in the Cayman Islands as well as from English common
law, the decisions of whose courts are of persuasive authority, but are not binding on a court in the Cayman Islands. The rights of our
shareholders and the fiduciary responsibilities of our directors under Cayman Islands law are different from what they would be under
statutes or judicial precedent in some jurisdictions in the United States. In particular, the Cayman Islands has a different body of securities
laws as compared to the United States, and certain states, such as Delaware, may have more fully developed and judicially interpreted
bodies of corporate law. In addition, Cayman Islands companies may not have standing to initiate a shareholders derivative action in a
federal court of the United States.
Provisions in our fifthsixth amended and restated
memorandum and articles of association may inhibit a takeover of us, which could limit the price investors might be willing to pay in
the future for our Class A ordinary shares and could entrench management.
Our fifthsixth amended and restated
memorandum and articles of association contain provisions that may discourage unsolicited takeover proposals that shareholders may consider
to be in their best interests. These provisions include a staggered board of directors and the ability of the board of directors to designate
the terms of and issue new series of preferred shares, which may make the removal of management more difficult and may discourage transactions
that otherwise could involve payment of a premium over prevailing market prices for our securities.
For the accountedaccounting period
ended December 31, 2024,2025, management identified a material weakness in internal controls related to the accounting for complex financial
instruments and review procedures around key reconciliations including accruals and payables.
The Company has not yet filed its Quarterly
Report on Form 10-Q for the quarters ending March 31, 2025, June 30, 2025 and September 30, 2025 (the “2025 10-Qs”) and thus
is not current in its SEC reporting obligations, which may result in any investment in our securities involving a greater degree of risk.
Although the Company has
dedicated significant resources to the completion of finalizing its consolidated financial statements and related disclosures for inclusion
in the 2025 Form 10-Qs, the Company was unable to file the 2025 Form 10-Qs on a timely basis. Additional time is needed by the Company
to complete its review of the financial statements included in the 2025 Form 10-Qs in order to ensure a complete, accurate Form 10-Q for
the quarters ended March 31, 2025, June 30, 2025 and September 30, 2025. The Company is working diligently to ensure accurate disclosures
are made in the 2025 Form 10-Qs and is working to file all three reports as promptly as practicable.
As a result of the Company
not being current in its SEC reporting obligations, investors need to evaluate certain decisions with respect to our securities in light
of a lack of current financial information. Accordingly, any investment in our securities could involve a greater degree of risk, and
such lack of current public information may have an adverse impact on investor confidence.
Finally, any of the events
described above, including the evolving and escalating conflict in Iran and the Middle East, and the ongoing impact of the recent conflict
between betweenthe Israel and Hamas and the Russia-Ukraine war, may also have
the effect of heightening many of the other risks described in
this “Risk Factors” section, such as those related to the market
for our securities and cross-border transactions.
Management's Discussion & Analysis (MD&A)
New heading “Amendment No. 1 to Business Combination Agreement”
New heading “Put Option Buyout Letter Agreement”
Removed heading “February 9, 2023”
Removed heading “Settlement of Payables”
Removed heading “Underwriting Agreement”
Removed heading “Administrative Support Agreement”
Largest changes
“In connection with the vote to approve the 2023 Extension Proposal, shareholders holding an aggregate of 23,403,515 shares of the Company’s Class A ordinary shares exercised their right to redeem their shares for a pro rata portion of the funds in the Trust Account (as defined below). As a result, $238,305,063 (approximately $10.18 per share) was withdrawn from the Trust Account (described below) to redeem such shares. Following the redemptions, there were 4,196,485 Class A ordinary shares issued and outstanding.”see in full comparison
“In connection with the vote to approve the March 2026 Extension Proposal, shareholders holding an aggregate of 7,984 shares of the Company’s Class A ordinary shares exercised their right to redeem their shares for a pro rata portion of the funds in the Trust Account (as defined below). As a result, approximately $0.09 million (approximately $11.84 per share) was withdrawn from the Trust Account to redeem such shares. Following the redemptions, there were 483,822 Class A ordinary shares issued and outstanding.”see in full comparison
Full comparison: every changed paragraph (57)
On January 17, 2023, Richard Chera informed
the Company of his decision to resign as Chief Executive Officer (“CEO”) and principal financial and accounting officer of
the Company, effective immediately. Mr. Chera’s resignation was voluntary and not the result of any disagreement with the operations,
policies or practices of the Company. Mr. Chera shall continue to serve as a director of the Company.
On January 17, 2023, the Board of Directors
of the Company (the “Board”) appointed Mr. Gavin Cuneo and Mr. Michael Minnick as co-CEOs of the Company, effective
immediately.
Additionally, in connection with this appointment,
each of Mr. Cuneo and Mr. Minnick entered into an Indemnity Agreement and a Letter Agreement with the Company on the same terms
as the Indemnity Agreements and Letter Agreements entered into by the directors and officers of the Company at the time of the Company’s
IPO. In addition, CIIG Management III LLC (“CIIG”) entered into the Letter Agreement. CIIG also entered into that certain
joinder agreement to the Registration Rights Agreement as described in further detail below.
On January 17, 2023, CIIG entered into a
Securities Assignment Agreement (the “Assignment Agreement”), by and among Crown PropTech Sponsor, LLC (“Crown PropTech
Sponsor”), CIIG and Richard Chera, whereby Crown PropTech Sponsor sold, transferred and assigned 5,662,000 Class B ordinary
shares of the Company and 250,667 private placement warrants to purchase Class A ordinary shares of the Company to CIIG. In connection
with entry into the Assignment Agreement, CIIG (i) entered into a Letter Agreement with the Company (the “Letter Agreement”)
and (ii) entered into a joinder agreement to the Registration Rights Agreement entered into by Crown PropTech Sponsor in connection
with the Company’s IPO. As a result of the above transaction CIIG became a co-sponsor to Crown (and together with Crown PropTech
Sponsor, the “Sponsors”).
In connection with the above transaction, Crown
PropTech Sponsor entered into a letter agreement dated as of January 17, 2023, whereby Crown PropTech Sponsor is no longer entitled
to receive any payments under the administrative services agreement and the Company is no longer required to pay any such payments. As
of the date of this Annual Report, the Company has not made any payments pursuant to the administrative agreement and does not expect
to incur any related expenses in the near future.
On May 5, 2023, Frits van Paasschen, a member
of the Board, chair of the Audit Committee of the Board, chair of the Nominating and Corporate Governance Committee of the Board, and
a member of the Compensation Committee of the Board, notified the Board of his resignation from the Board, effective upon the acceptance
by the Board, which the Board accepted on May 8, 2023. Mr. van Paasschen’s resignation was voluntary and not the result
of any disagreement with the operations, policies or practices of the Company.
On May 8, 2023, the Board elected Chris Rogers
as a member of the Board, chair of the Audit Committee of the Board, a member of the Nominating and Corporate Governance Committee of
the Board, and a member of the Compensation Committee of the Board, effective immediately.
February 9, 2023
Beginning on January 31, 2023, and continuing
until the Company’s February 9, 2023 extraordinary general meeting of shareholders (“Extraordinary General Meeting”),
the Company and CIIG entered into certain non-redemption agreements and assignments of economic interests (the “Non-Redemption Agreements”)
with certain investors (the “Non-Redeeming Investors”). The Non-Redemption Agreements provide for the assignment of economic
interest of an aggregate of 1,500,000 Class B ordinary shares held by CIIG to the Non-Redeeming Investors in exchange for such Non-Redeeming
Investors agreeing to hold and not redeem an aggregate of 4,000,000 Class A ordinary shares at the Extraordinary General Meeting.
Pursuant to the Non-Redemption Agreements, CIIG has agreed to transfer to such Non-Redeeming Investors an aggregate of 1,500,000 Class A
ordinary shares upon conversion of the Class B ordinary shares in connection with the consummation of an initial Business Combination.
On February 9, 2023, the Company’s
shareholders approved an amendment to amend and restate the Company’s Amended and Restated Memorandum and Articles of Association
to extend the date by which the Company must consummate an initial Business Combination from February 11, 2023 to February 11,
2024 (the “2023 Extension Proposal”).
In connection with the vote to approve the 2023
Extension Proposal, shareholders holding an aggregate of 23,403,515 shares of the Company’s Class A ordinary shares exercised
their right to redeem their shares for a pro rata portion of the funds in the Trust Account (as defined below). As a result, $238,305,063
(approximately $10.18 per share) was withdrawn from the Trust Account (described below) to redeem such shares. Following the redemptions,
there were 4,196,485 Class A ordinary shares issued and outstanding.
March 9, 2026
On March 9, 2026, the Company’s shareholders approved an amendment to amend and restate the Company’s Fifth Amended and Restated Memorandum and Articles of Association to extend the date by which the Company must consummate an initial Business Combination from March 11, 2026 to March 11, 2027 (the “March 2026 Extension Proposal”).
In connection with the vote to approve the March 2026 Extension Proposal, shareholders holding an aggregate of 7,984 shares of the Company’s Class A ordinary shares exercised their right to redeem their shares for a pro rata portion of the funds in the Trust Account (as defined below). As a result, approximately $0.09 million (approximately $11.84 per share) was withdrawn from the Trust Account to redeem such shares. Following the redemptions, there were 483,822 Class A ordinary shares issued and outstanding.
Associated with the March 9, 2026 Extraordinary General Meeting, the Company and CIIG entered into non-redemption agreements (the “March 2026 Non-Redemption Agreements”) with certain investors pursuant to which, if such investors do not redeem (or validly rescind any redemption requests on) their Class A ordinary shares of the Company (the “March 2026 Non-Redeemed Shares”) in connection with the March 2026 Extraordinary General Meeting, CIIG agreed to transfer to such investors Class B ordinary shares held by CIIG immediately following the consummation of an initial Business Combination if they continue to hold such March 2026 Non-Redeemed Shares through the March 9, 2026 Extraordinary General Meeting.
The March 2026 Non-Redemption Agreements provided for the assignment of 11,529 Class B ordinary shares, par value $0.0001 per share, held by CIIG that will accrue on a monthly basis beginning on April 11, 2026 to the investors until the completion of an initial Business Combination in exchange for such Investors agreeing to hold and not redeem certain public shares at the March 9, 2026 Extraordinary General Meeting.
On July 2, 2025, (i) the
Company (“SPAC”),
(ii) Mkango (Cayman) Limited, an exempted company limited by shares incorporated under the laws of the Cayman
Islands and a direct wholly
owned Subsidiary of LancasterMKAR (as defined below) (“Merger Sub”), (iii) Mkango Rare Earths Limited (f/k/a
Lancaster Exploration Limited,Limited), a company organized
under the laws of the British Virgin Islands (“LancasterMKAR”, and from and after
the Closing, “PubCo”), and a direct,
wholly owned subsidiary of Mkango Resources Ltd., a company organized under the laws
of British Columbia, Canada (the “Selling Shareholder”),
(iv) Mkango Polska s.p. Z.o.o., a company organized under the laws
of Poland and a direct, wholly owned subsidiary of Selling Shareholder
(“MKA Poland”), (v) Mkango ServiceCo UK Limited, a
company organized under the laws of England and a direct, wholly owned
subsidiary of Selling Shareholder (“Mkango ServiceCo”),
and (vi) MKA Exploration Ltd., a company organized under the laws
of the British Virgin Islands and a direct, wholly owned subsidiary
of Selling Shareholder (“MKA BVI”, and together with Lancaster,
MKAR, MKA Poland and Mkango ServiceCo, the “Companies” and,
each, a “Company”) entered into a business combination agreement
(the “Business Combination Agreement”).
Amendment No. 1 to Business Combination Agreement
On February 13, 2026, SPAC and MKAR entered into Amendment No. 1 to the Business Combination Agreement (“Amendment No. 1”). Amendment No. 1, among other things, amends the pre-closing internal corporate reorganization to establish the ownership structure so that MKAR will own the assets and operations associated with the rare earth project at Songwe Hill in Malawi and the proposed separation plant to be constructed in Pulawy, Poland and extends the Outside Date from March 11, 2026 to September 30, 2026, with an automatic extension to December 31, 2026 if the U.S. Securities and Exchange Commission (the “SEC”) has not declared the Proxy/Registration Statement effective by August 14, 2026.
On June 1, 2025, the Company
engaged Jett Capital
Advisors, LLC (“Jett Capital”) as financial advisor to advise the Company on their proposed Business
Combination with Lancaster
Exploration Limited,MKAR, Mkango Polska S.P.Z.O.O., MKA BVI, and Mkango ServiceCo UK Limited.
Put Option Buyout Letter Agreement
On June 2, 2025, MKAR agreed to issue and sell a convertible promissory note to an affiliate of the Company’s Chairman (the “Investor”) in connection with the Proposed Business Combination with a principal amount of $500,000 (the “BCA Note”), as described in the Note Purchase Agreement in the Company’s Form 8-K filed with the SEC on June 3, 2025.
The Company’s CEO and an affiliated entity of the CEO, entered into a letter agreement (the “Letter Agreement”) with the Investor. The Letter Agreement includes a put option buyout by the Company’s CEO and/or an affiliated entity of the CEO in the event if for any reason whatsoever Investor is entitled to the repayment of the BCA Note (including, without limitation unpaid and accrued interest and other charges owing pursuant to the terms of the BCA Note), and such payment was not timely made by MKAR.
Settlement of Payables
For the years ended December 30, 2024 and 2023,
the Company did not settle any payables with vendors or related parties, reporting aggregate amounts of $0 for both periods in accordance
with ASC Topic 405, “Liabilities.” The 2023 settlement of payables of $339,107 with related parties is in relation to the
Administrative Services Agreement. As this is with a related party, the Company recognized $339,107 in the statement of changes in shareholders’
deficit for the settlement of these payables. The remaining $420,536 was recognized as a gain in the statement of operations. There were
no settled payables for the year ended December 31, 2024.
For the year ended December 31, 2025, we had net loss of $3,013,571. We incurred $3,024,671 of operating costs and non-redemption agreement expense of $223,138 partially offset by a change in fair value of warrant liabilities of $14 and trust dividend income of $234,224.
For the year ended December 31, 2023, we had net
income of $523,546. We generated income in our trust account for $3,372,354 and settled payables of $420,536 partially offset by $2,112,830
in operating costs, $1,156,500 in non-redemption agreement expense and $14 from a change in the fair value of the warrant liabilities.
For the year ended December 31, 2025, cash used in operating activities was $1,108,724, resulting from a net loss of $3,013,571 which was impacted non-redemption agreement expense of $223,138 change in fair value of warrant liabilities of $14, trust dividend income of $234,224 and changes in operating assets and liabilities of $1,915,947.
For the year ended December 31, 2023, cash used
in operating activities was $917,716, resulting from the net income of $523,546 which was impacted by unrealized loss on change in fair
value of warrant liabilities of $14, settlement of payables of $420,536, non-redemption agreement expense associated with the non-redemption
agreements of $1,156,500, trust dividend income of $3,372,354 and changes in operating assets and liabilities of $1,195,114.
As of December 31, 20242025 and 2023,2024, we had cash
outside the trust
account of $425 and $652, respectively, available for working capital needs and working capital deficits of $2,977,586$5,297,042 and $2,277,105,$2,977,586, respectively.
respectively. All remaining cash held in the trust account is generally unavailable for our use, prior to an initial business combination,
and is restricted
for use either in a business combination or to redeem ordinary shares. As of December 31, 20242025 and 2023,2024, none of
the amount in the trust
account was available to be withdrawn as described above.
On November 30, 2021, wethe Company entered into
a convertible
note with Richard Chera, ourits former Chief Executive Officer and Director,director, pursuant to which Mr. Chera agreed to loan usthe
Company up to an
aggregate principal amount of $1,500,000 (the “Convertible Note”). The Convertible Note was non-interest
bearing and due on
the earlier of: (i) 12 months from the date thereof or (ii) the date on which wethe consummateCompany consummates a businessBusiness combination. Combination.
If wethe do
Company does not consummate a businessBusiness combination,Combination, wethe Company may use a portion of any funds held outside the trustTrust accountAccount to
repay the Convertible Note;
however, no proceeds from the trustTrust accountAccount may be used for such repayment if wethe doCompany does not consummate
the aBusiness businessCombination. combination.Up Onto May 31,
2023, and effective as$1,500,000 of January 17, 2023, the Convertible Note wasmay amendedbe andconverted restatedinto warrants at a price of $1.50 per warrant at the
option of Mr. Chera (the “A&RConversion NoteRight”). inThe the
aggregatewarrants principalwould amountbe of upidentical to $1,000,000 to be due on the earlierPrivate of:Placement (i) February 11, 2024; (ii) the date on which the
Company consummates a Business Combination or (iii) the effective date of a liquidation of the Company. Additionally, due to a waiver
by Mr. Chera, the A&R Note no longer provides for the Conversion Right.Warrants.
On MarchMay 28,31, 2025, and effective as of February
11, 2024,2023, the Convertible Note was amended
and restated (the “A&R Note”) in the aggregate principal amount of up to $1,000,000 was amended to be due on the earlier of: (i) February
11, 20262024; (ii) the date on which the Company consummates a Business Combination; or (iii) the effective date of a liquidation of the Company.
Additionally, due to a waiver by Mr. Chera, the A&R Note no longer provides for the Conversion Right.
On March 28, 2025, the A&R Note in the aggregate principal amount of up to $1,000,000 was amended to be due on the earlier of: (i) February 11, 2026; (ii) the date on which the Company consummates a Business Combination; or (iii) the effective date of a liquidation of the Company (“Second A&R Note”).
On February 10, 2026, the Second A&R Note was amended to be due on the earlier of: (i) December 31, 2026; (ii) the date on which the Company consummates a Business Combination; or (iii) the effective date of a liquidation of the Company (“Third A&R Note”). In connection with the execution of the Third A&R Note, CIIG Management III LLC has agreed to transfer additional Class B Ordinary Shares to an unaffiliated third party in an amount equal to the product of the number of months from February 2026 until the date on which SPAC consummates a Business Combination and 2,500 and subject to the same transfer restrictions that are imposed on CIIG Management III LLC.
For the year ended December 31, 2025, CIIG has advanced funds to and paid expenses on behalf of the Company in the amount of $1,108,724. Of these funds, $403,459 is reported as due to related parties on the balance sheet. These borrowings are non-interest bearing. The remaining $705,215 is reported on the statements of changes in shareholders’ deficit as a capital contribution from Sponsor.
Borrowing under the A&R Note and the advances from CIIG are reported on the balance sheets as due to related parties. At December 31, 2025 and 2024, the Company reported $1,592,586 and $1,189,077, respectively, on the balance sheets.
The holders of the Founder
Shares, Private Placement
Warrants and any warrants that may be issued upon conversion of working capital loans (and any ordinary shares
issuable upon the exercise
of the Private Placement Warrants or warrants issued upon conversion of the working capital loans and upon
conversion of the Founder Shares)
are entitled to registration rights pursuant to a registration rights agreement signed prior to the
effective date of the IPO requiring
the Company to register such securities for resale. The holders of these securities will be entitled
to make up to three demands, excluding
short form demands, that the Company register such securities. In addition, the holders have certain
“piggyback” registration
rights with respect to registration statements filed subsequent to the completion of a business combination.
The Company will bear the
expenses incurred in connection with the filing of any such registration statements. On November 10, 2021 (but effective as of the
closing of the Brivo Business Combination), and as part of the Brivo Business Combination, New Brivo, Crown PropTech Sponsor, Anchor Investor
and certain other shareholders and directors and officers of Crown and Brivo entered into the Amended and Restated Registration Rights
Agreement. As part of the termination of the Business Combination, the Restated Registration Rights Agreement was automatically terminated.
Underwriting Agreement
A deferred underwriting discount of $0.35 per
Unit, or $9,660,000 in the aggregate, was payable to the underwriters from the amounts held in the Trust Account solely in the event that
we complete an initial business combination, subject to the terms of the underwriting agreement. In December 2022, the underwriters agreed
to waive their right to receive any additional deferred underwriting discount and as a result, the Company de-recognized the related deferred
underwriting discount. The Company considers the deferred underwriting discount an offering cost. Offering costs are charged to shareholders’
equity or statement of operations based on the relative value of the Public Warrants to the proceeds received from the Units sold upon
the completion of the IPO. Upon the waiver of the deferred underwriting discount, a portion of the deferred underwriting discount was
recorded to the statement of operations and to shareholders’ equity. For the year ended December 31, 2022, in relation to the waiver
of the deferred underwriting discount, the Company recognized other income of $479,780 for offering costs related to warrant issuance
and an increase in additional paid-in capital of $9,180,220.
As discussed above, on June
1, 2025, the Company engaged Jett Capital as financial advisor to advise the Company on their proposed Business Combination with LancasterMKAR,
Exploration Limited, Mkango Polska S.P.Z.O.O., MKA BVI, and Mkango ServiceCo UK Limited. Except for $100,000 due upon execution of the
agreement, fees for
such services will be payable only upon consummation of an initial business combination by us.
Administrative Support Agreement
We previously entered into an administrative agreement
to pay Crown PropTech Sponsor or an affiliate thereof a total of up to $15,000 per month for office space, utilities, secretarial and
administrative support services provided to members of our management team (the “Administrative Support Payments”). Pursuant
to a subsequent letter agreement, Crown PropTech Sponsor is no longer entitled to receive any Administrative Support Payments and we are
no longer required to pay any such payments. As of December 31, 2024 and 2023, we have not made any payments pursuant to the administrative
agreement and do not expect to incur any related expenses in the near future. As the waiver of the Administrative Support Payments is
with a related party, the Company recognized $339,107 in the statement of changes in shareholders’ deficit for the settlement of
these transactions for the year ended December 31, 2023.
Attorney Fees
We incurred legal fees in connection with the
proposed Brivo Business Combination, none of which were payable until consummation of the proposed Brivo Business Combination. As of December
31, 2023, we fully paid a settled amount in legal fees associated with the Brivo Business Combination.
On February 10, 2026, the Second A&R Note was amended to replace “February 11, 2026” with December 31, 2026 (the “Third A&R Note”). In connection with the execution of the Third A&R Note, CIIG Management III LLC has agreed to transfer additional CPTK Class B Ordinary Shares to an unaffiliated third party in an amount equal to the product of the number of months from February 2026 until the date on which SPAC consummates a Business Combination and 2,500 and subject to the same transfer restrictions that are imposed on CIIG Management III LLC.
MKAR F-4 Note
In connection with the previously disclosed $750,000 Note Purchase Agreement (the “NPA”) entered into with MKAR on June 3, 2025, CIIG Management III LLC, in its capacity as the F-4 Note Investor, funded the remaining $250,000 in connection with the confidential submission of the Form F-4 in exchange for MKAR’s issuance of a convertible promissory note on February 13, 2026.
The preparation of these
financial statements
in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts
of assets and liabilities
and disclosure of contingent assets and liabilities at the date of the financial statements and the reported
amounts of expenses during
the reporting period. Actual results could differ from those estimates. We have not identified any critical
accounting estimates.estimates other than the non-redemption agreement discussed below.
In 2024, the Company and CIIG entered into certain
non-redemption agreements and assignments of economic interests (the “Non-Redemption Agreements”) with certain investors (the
“Non-Redeeming Investors”). The Non-Redemption Agreements provide for the
assignment of economic interest of Class B ordinary
shares held by CIIG to the Non-Redeeming Investors in exchange for such Non-Redeeming
Investors agreeing to hold and not redeem Class
A ordinary shares at the Extraordinary General Meetings. Pursuant to the Non-Redemption
Agreements, CIIG has agreed to transfer to such
Non-Redeeming Investors Class A ordinary shares upon conversion of the Class B
ordinary shares in connection with the consummation of
an initial Business Combination. The Company estimated the aggregate fair value
of the Class B ordinary shares attributable to the Non-Redeeming Investors to be $451,322 (or $0.78 per share) for the year ended
December 31, 2024. For the year ended December 31, 2023,2024, the Company estimated the aggregate fair value of the Class B ordinary
shares shares
attributable to the Non-Redeeming Investors to be $1,156,500$451,322 or $0.77.$0.78 per share.
Beginning on May 6, 2025, and continuing until the May 9, 2025 Extraordinary General Meeting, the Company and CIIG entered into Non-Redemption Agreements with the Non-Redeeming Investors. The Non-Redemption Agreements provide for the assignment of economic interest of an aggregate of 115,287 Class B ordinary shares held by CIIG to the Non-Redeeming Investors in exchange for such Non-Redeeming Investors agreeing to hold and not redeem an aggregate of 461,146 Class A ordinary shares at the May 9, 2025 Extraordinary General Meeting. Pursuant to the Non-Redemption Agreements, CIIG has agreed to transfer to such Non-Redeeming Investors an aggregate of 115,287 Class A ordinary shares upon conversion of the Class B ordinary shares in connection with the consummation of an initial Business Combination. For the year ended December 31, 2025, the Company estimated the aggregate fair value of the 115,287 Class B ordinary shares attributable to the Non-Redeeming Investors to be $223,138 or $1.94 per share.
In March 2026 the Company and CIIG entered into non-redemption agreements (the “March 2026 Non-Redemption Agreements”) with certain investors pursuant to which, if such investors do not redeem (or validly rescind any redemption requests on) their Class A ordinary shares of the Company (the “March 2026 Non-Redeemed Shares”) in connection with the March 9, 2026 Extraordinary General Meeting, CIIG will assign one Class B ordinary share, par value $0.0001 per share for each 40 public shares not redeemed, accruing monthly beginning April 11, 2026 until the completion of the initial Business Combination, held by CIIG to the investors in exchange for such investors agreeing to hold and not redeem certain public shares at the March 9, 2026 Extraordinary General Meeting.
The March 2026 Non-Redemption Agreements provided for the assignment of 11,529 Class B ordinary shares, par value $0.0001 per share, held by CIIG to the investors, accruing monthly beginning April 11, 2026 until the completion of the initial Business Combination, in exchange for such Investors agreeing to hold and not redeem certain public shares at the March 9, 2026 Extraordinary General Meeting.
We utilized a model to determine
the fair value
of the Non-Redemption Agreements using observable and unobservable assumptions about current and anticipated events. Significant
assumptions assumptions
include the probability and timing of consummating a business combination. Significant variations in these assumptions could
have a material
impact to the financial statements. The Company estimated the aggregate fair value of the Class B ordinary shares
attributable to the Non-Redeeming Investors to be $223,138 (or $1.94 per share) for the year ended December 31, 2025. For the year ended
December 31, 2024, the Company estimated the aggregate fair value of the Class B ordinary shares attributable to the Non-Redeeming Investors
to be $451,322 or $0.78.
Recent Accounting PronouncementsStandards
On July 4, 2025, President
Trump signed into law the One Big Beautiful Bill Act (“OBBBA”). ASC 740, “Income Taxes”,
requires the effects of changes in tax laws to be recognized in the period in which the legislation is enacted. The Company is currently
evaluating the impact of the new law. However, none of the tax provisions are expected to have a significant impact on the Company’s
financial statements.
In November 2023, the FASB issued ASU 2023-07,
“Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures” (“ASU 2023-07”), which improves
reportable segment disclosure requirements, primarily through enhanced disclosures about significant segment expenses among other disclosure
requirements. ASU 2023-07 is effective for fiscal years beginning after December 15, 2023, and interim periods within fiscal years beginning
after December 15, 2024. Early adoption is permitted. The Company’s management has determined the adoption of ASU 2023-07 does not
have a material impact on its financial statements and disclosures.
In December 2023, the2023 FASB issued
ASU 2023-09,
“Income Taxes (Topic 740): Improvements to Income Tax Disclosures” (“ASU 2023-09”), which requiresamends disclosureASC 740, “Income Taxes”, to improve the transparency
and decision usefulness of incremental income tax information within the rate reconciliation and expanded disclosures offor all entities subject to income taxes paid,for among other disclosure
requirements. ASU 2023-09 is effective forthe fiscal years beginning after December 15,
31, 2024. EarlyThe adoptionCompany evaluated requirements for the new standard and determined that it is permitted.not Theapplicable Company’s
managementas hasit determined the adoption of ASU 2023-09 willis not havesubject ato material impact on its financial statements and disclosures.income
taxation.
What changed in the latest 10-Q
Risk Factors
Factors that could cause our actual results to differ materially from those in this Quarterly Report on Form 10-Q include the risks described in our Annual Report on Form 10-K for the year ended December 31, 2025 filed with the SEC on March 31, 2026. Any of these factors could result in a significant or material adverse effect on our business, financial condition or future results. Additional risks and uncertainties not presently known to us or that we currently deem immaterial may also impair our business or results of operations.
No wording changes found in this section.
Full comparison: every changed paragraph (0)
Management's Discussion & Analysis (MD&A)
New heading “Amendment No. 2 to Business Combination Agreement”
Largest changes
“In connection with the execution of Amendment No. 2, SPAC and MKAR agreed to amend and restate the form of Registration Rights and Lock-Up Agreement to be entered into at Closing to, among other things, amend certain definitions, grant the Selling Shareholder certain rights to include for resale an allotted number of its MKAR Shares in any subsequent registered offering of MKAR shares, and exclude certain SPAC Class B Ordinary Shares to be transferred by the Sponsors pursuant to certain previously disclosed non-redemption agreements to unaffiliated third parties at Closing from certain …”see in full comparison
“In connection with the proposed Business Combination, MKAR and the Company have filed a registration statement on Form F-4 (SEC File No. 333-296089) (the “Registration Statement”) with the Securities and Exchange Commission (“SEC”) , including a preliminary proxy statement of the Company and a preliminary prospectus of MKAR with respect to the securities to be offered in the proposed Business Combination.”see in full comparison
“On June 1, 2025, the Company engaged Jett Capital Advisors, LLC (“Jett Capital”) as financial advisor to advise the Company on their proposed Business Combination with MKAR, Mkango Polska S.P.Z.O.O., MKA BVI, and Mkango ServiceCo UK Limited. …”see in full comparison
“For the three months ended June 30, 2025, we had net loss of $1,204,678. We incurred $1,005,463 of operating costs, non-redemption agreement expense of $223,138 and change in fair value of warrant liabilities of $35,519 partially offset by trust dividend income of $59,442 For the six months ended June 30, 2026, we had net loss of $3,064,866. We incurred $2,009,949 of operating costs, non-redemption agreement expense of $123,821, loan extension agreement expense of $37,212, and change in fair value of warrant liabilities of $994,933 partially offset by a trust dividend income of $101,049.”see in full comparison
“As of June 30, 2026, the Loan Extension Agreement accrued 12,500 Class B ordinary shares. The Company estimated the aggregate fair value of the 12,500 Class B ordinary shares attributable to the Loan Extension Agreement, for the period ended June 30, 2026, to be $37,212. This implies a value of $2.98 per share that vested during the six months ended June 30, 2026. For the three and six months ended June 30, 2026, the Company recognized an expense of $26,850 and $37,212, respectively, for the Loan Extension Agreement. No expense was recognized in the three and six months ended June 30, 2025.”see in full comparison
Full comparison: every changed paragraph (22)
In connection with the proposed Business Combination, MKAR and the Company have filed a registration statement on Form F-4 (SEC File No. 333-296089) (the “Registration Statement”) with the Securities and Exchange Commission (“SEC”) , including a preliminary proxy statement of the Company and a preliminary prospectus of MKAR with respect to the securities to be offered in the proposed Business Combination.
On February 13, 2026, SPACthe Company and MKAR entered into
Amendment No. 1 to the Business Combination Agreement (“Amendment No. 1”). Amendment No. 1, among other things, amendsamended the
pre-closing internal corporate reorganization to establish the ownership structure so that MKAR will own the assets and operations associated
with the rare earth project at Songwe Hill in Malawi and the proposed separation plant to be constructed in Pulawy, Poland and extends
extended the Outside Date from March 11, 2026 to September 30, 2026, with an automatic extension to December 31, 2026 if the U.S. Securities and
Exchange Commission (the “SEC”) hasdid not declareddeclare the Proxy/Registration Statement effective by August 14, 2026. Because the Proxy/Registration Statement was not declared effective by August 14, 2026, the Outside Date was automatically extended to December 31, 2026.
Amendment No. 2 to Business Combination Agreement
On May 20, 2026, SPAC and MKAR entered into Amendment No. 2 to the Business Combination Agreement (“Amendment No. 2”) to, among other things, amend certain definitions and provisions relating to the Exchange Ratio and share issuances by MKAR prior to the Closing, and to set forth the settlement of intercompany indebtedness through a debt-to-equity exchange by Mkango and MKAR as a condition to the Closing.
In connection with the execution of Amendment No. 2, SPAC and MKAR agreed to amend and restate the form of Registration Rights and Lock-Up Agreement to be entered into at Closing to, among other things, amend certain definitions, grant the Selling Shareholder certain rights to include for resale an allotted number of its MKAR Shares in any subsequent registered offering of MKAR shares, and exclude certain SPAC Class B Ordinary Shares to be transferred by the Sponsors pursuant to certain previously disclosed non-redemption agreements to unaffiliated third parties at Closing from certain transfer restrictions during the Lock-Up Period (as defined in the Registration Rights and Lock-Up Agreement).
Amended and Restated Financial Advisor ServiceAdvisory Agreement
On June 1, 2025, the Company engaged Jett Capital Advisors, LLC (“Jett Capital”) as financial advisor to advise the Company on their proposed Business Combination with MKAR, Mkango Polska S.P.Z.O.O., MKA BVI, and Mkango ServiceCo UK Limited. On May 20, 2026, as amended and restated on June 8, 2026, Jett Capital, the Company, MKAR, and the financial advisors to MKAR entered into an agreement relating to the provision of mergers and acquisitions advisory services in connection with the Business Combination Agreement, as amended, to provide that the financial advisors party thereto have the discretion to receive Advisor Compensation Shares in lieu of cash immediately prior to the closing of the business combination for services rendered.
On June 1, 2025, the Company engaged Jett Capital
Advisors, LLC (“Jett Capital”) as financial advisor to advise the Company on their proposed Business Combination with MKAR,
Mkango Polska S.P.Z.O.O., MKA BVI, and Mkango ServiceCo UK Limited.
For the three months ended MarchJune 31,30, 2026, we
had net loss of $1,029,307.$2,035,559. We incurred $1,069,505$940,444 of operating costscosts, andnon-redemption $10,362agreement inexpense of $123,821, loan extension agreement expense of $26,850, and change in fair value of warrant liabilities of $994,933 partially offset
by a trust dividend income of $50,560.$50,489.
For the three months ended June 30, 2025, we had net loss of $1,204,678. We incurred $1,005,463 of operating costs, non-redemption agreement expense of $223,138 and change in fair value of warrant liabilities of $35,519 partially offset by trust dividend income of $59,442 For the six months ended June 30, 2026, we had net loss of $3,064,866. We incurred $2,009,949 of operating costs, non-redemption agreement expense of $123,821, loan extension agreement expense of $37,212, and change in fair value of warrant liabilities of $994,933 partially offset by a trust dividend income of $101,049.
For the threesix months ended MarchJune 31,30, 2025, we
had net loss of $712,127.$1,916,805. We incurred $772,793$1,778,256 of operating costs, non-redemption agreement expense of $223,138 and change in fair value of warrant liabilities of $35,519 partially offset by trust dividend income of $60,666.$120,108.
For the threesix months ended MarchJune 31,30, 2026, cash
used in operating activities was $629,334,$960,589, resulting from a net loss of $1,029,307$3,064,866 which was impacted by trust dividend income of $50,560,
$101,049, loan extension agreement expense of $10,362$37,212, non-redemption agreement expense of $123,821, change in fair value of warrant liabilities of $994,933 and changes in operating assets and liabilities of $440,171.$1,049,360.
For the threesix months ended MarchJune 31,30, 2025, cash
used in operating activities was $86,142,$269,691, resulting from a net loss of $712,127$1,916,805 which was impacted non-redemption agreement expense of $223,138 change in fair value of warrant liabilities of $35,519, trust dividend income of $60,666$120,108 and
changes in operating assets and liabilities of $686,651.$1,508,565.
As of MarchJune 31,30, 2026 and December 31, 2025, we
had cash outside the trust account of $425 available for working capital needs and working capital deficits of $5,737,213$6,346,402 and $5,297,042,
respectively. All remaining cash held in the trust account is generally unavailable for our use, prior to an initial business combination,
and is restricted for use either in a business combination or to redeem ordinary shares. As of MarchJune 31,30, 2026 and December 31, 2025, none
of the amount in the trust account was available to be withdrawn as described above.
Through MarchJune 31,30, 2026, our liquidity needs were
satisfied through receipt of $25,000 from the sale of the Founder Shares, the remaining net proceeds from the Initial Public Offering,
the sale of Private Placement Warrants, the Promissory Note and the Convertible Note (as defined below) and capital contributions from
the Sponsors of $2,007,967.$2,339,222.
For the threesix months ended MarchJune 31,30, 2026, CIIG
has paid expenses on behalf of the Company in the amount of $629,334$960,589 and is reported on the statements of changes in shareholders’
deficit as a capital contribution from Sponsor.
Borrowing under the A&R Note and the advances
from CIIG are reported on the balance sheets as due to related parties. At MarchJune 31,30, 2026 and December 31, 2025, the Company reported
$1,592,586 on the balance sheets.
The preparation of these unaudited condensed financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the unaudited condensed financial statements and the reported amounts of expenses during the reporting period. Actual results could differ from those estimates. We have not identified any critical accounting estimates other than the non-redemption agreement and loan extension agreement discussed below.
Beginning on May 6, 2025, and continuing until
the May 9, 2025 Extraordinary General Meeting, the Company and CIIG entered into Non-Redemption Agreements with the Non-Redeeming Investors.
The Non-Redemption Agreements provide for the assignment of economic interest of an aggregate of 115,287 Class B ordinary shares held
by CIIG to the Non-Redeeming Investors in exchange for such Non-Redeeming Investors agreeing to hold and not redeem an aggregate of 461,146
Class A ordinary shares at the May 9, 2025 Extraordinary General Meeting. Pursuant to the Non-Redemption Agreements, CIIG has agreed to
transfer to such Non-Redeeming Investors an aggregate of 115,287 Class A ordinary shares upon conversion of the Class B ordinary shares
in connection with the consummation of an initial Business Combination. For the three and six months ended MarchJune 31,30, 2026,2025, the Company estimated
the aggregate fair value of the 115,287 Class B ordinary shares attributable to the Non-Redeeming Investors to be $223,138 or $1.94 per
share.
For the three and six months ended June 30, 2026, the March 2026 Non-Redemption Agreements accrued 34,587 Class B ordinary shares. The Company estimated the aggregate fair value of the 34,587 Class B ordinary shares attributable to the March 2026 Non-Redemption Agreements, for the three and six months ended June 30, 2026, to be $123,821. This implies a value of $3.58 per share that vested during the three and six months ended June 30, 2026.
As of June 30, 2026, the Loan Extension Agreement accrued 12,500 Class B ordinary shares. The Company estimated the aggregate fair value of the 12,500 Class B ordinary shares attributable to the Loan Extension Agreement, for the period ended June 30, 2026, to be $37,212. This implies a value of $2.98 per share that vested during the six months ended June 30, 2026. For the three and six months ended June 30, 2026, the Company recognized an expense of $26,850 and $37,212, respectively, for the Loan Extension Agreement. No expense was recognized in the three and six months ended June 30, 2025.
As of MarchJune 31,30, 2026, we did not have any off-balance
sheet arrangements as defined in Item 303(a)(4)(ii) of Regulation S-K.
CPTKW insider buying and selling (Form 4)
Since 2026-04-11, insiders reported open-market purchases in 0 Form 4 filings and open-market sales in 0 filings. Totals add up every open-market (code P and S) line in those filings, using the prices reported in the filings. Awards, option exercises, tax withholding and gifts are listed below but not counted.
No Form 4 stock transactions in this period.
Well-known investors holding CPTKW (13F)
None of the 59 investors we track reported a position in their latest 13F.